FA
GEN

Friess Associates’s Genesis Healthcare, Inc. GEN Stock Holding History

Friess Associates’s Portfolio GEN Stock Details GEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-80,000
Closed -$490K – 188
2015
Q3 		$490K Buy
+80,000
New +$543K 0.05% 111

Other funds holding GEN

HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
CPA
Columbia Pacific Advisors Seattle, Washington $31M AUM 29.53% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCM
Mazama Capital Management Portland, Oregon $544M AUM 9.52% 1-Year Est. Return

Friess Associates's GEN Position: Q4 2015 in Review

Friess Associates sold out of Genesis Healthcare, Inc. (GEN) in Q4 2015, closing a stake of 80,000 shares — an estimated $490K sold.

Friess Associates first reported a position in GEN in Q3 2015 and held it in 1 quarter. The position peaked at $490K in Q3 2015. 82 funds tracked by Wall St. Rank hold GEN as of Q4 2015.

  • Friess Associates reported no remaining Genesis Healthcare, Inc. position as of Q4 2015 after selling out during the quarter.
  • Friess Associates sold 80,000 Genesis Healthcare, Inc. shares in Q4 2015, an estimated $490K.
  • Friess Associates first reported a position in Genesis Healthcare, Inc. in Q3 2015 and held it in 1 quarter.
  • Friess Associates's Genesis Healthcare, Inc. position peaked at $490K in Q3 2015.
  • 82 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q4 2015.

Based on Friess Associates's 13F filing for Q4 2015, filed 12 Feb 2016.